Dabbous Alia S, Jabbour-Khoury Samar I, Nasr Viviane G, Moussa Adib A, Zbeidy Reine A, Khouzam Nabil E, El-Khatib Mohamad F, Baraka Anis S
Department of Anesthesiology, American University of Beirut-Medical Center, Beirut, Lebanon.
Middle East J Anaesthesiol. 2010 Feb;20(4):565-70.
In a prospective randomized double-blind study, we compared the effectiveness of dexamethasone 8 mg with either granisetron 1 mg or ondansetron 4 mg in the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic surgery. Hundred ASA I and II patients scheduled for laparoscopic surgery were enrolled in the study and 84 patients completed it. Following induction of anesthesia, group I (n=42) received granisetron 1 mg and dexamethasone 8 mg, group II (n=42) received ondansetron 4 mg and dexamethasone 8 mg. Nausea and vomiting episodes, pain scores as well as side effects were recorded during the first hour and subsequently during the first 6 and 24 hours postoperatively. Satisfaction scores were obtained at discharge. There was no statistically significant difference between the 2 groups during the 1st 24 hours following surgery in regards to pain scores, satisfaction and side effects manifestations. At 0-1 hour interval, 100% of patients in group I and 97.6% in group II had no vomiting. Total response (no moderate or severe nausea and no rescue antiemetics) was 83.3% in group I and 80.95% in group II, and metoclopramide was used in 7.1% of patients in both groups. At 1-6 hours interval, 97.6% of patients in group I and 100% in group II had no vomiting. Total response was 92.8% in group I and 90.9% in group II, and metoclopramide was used in 4.76% of patients in group I and 2.38% in group II. At 6-24 hours no vomiting occurred in 97.6% of patients in group I and 100% in group II. Total response was 95.2% in both groups, and metoclopramide was used in 2.38% of patients in both groups. In conclusion, the combination of dexamethasone 8 mg with either granisetron 1 mg or ondansetron 4 mg following induction of anesthesia in patients undergoing laparoscopic surgery showed no statistically significant difference in antiemetic efficacy with minimal side effects and excellent patient satisfaction.
在一项前瞻性随机双盲研究中,我们比较了8毫克地塞米松与1毫克格拉司琼或4毫克昂丹司琼在预防腹腔镜手术患者术后恶心和呕吐方面的有效性。100例计划进行腹腔镜手术的ASA I级和II级患者纳入本研究,84例患者完成研究。麻醉诱导后,I组(n = 42)接受1毫克格拉司琼和8毫克地塞米松,II组(n = 42)接受4毫克昂丹司琼和8毫克地塞米松。记录术后第1小时以及随后术后6小时和24小时内的恶心和呕吐发作次数、疼痛评分以及副作用。出院时获得满意度评分。术后24小时内,两组在疼痛评分、满意度和副作用表现方面无统计学显著差异。在0 - 1小时时间段,I组100%的患者和II组97.6%的患者未发生呕吐。I组的总有效率(无中度或重度恶心且未使用抢救性止吐药)为83.3%,II组为80.95%,两组均有7.1%的患者使用了甲氧氯普胺。在1 - 6小时时间段,I组97.6%的患者和II组100%的患者未发生呕吐。I组的总有效率为92.8%,II组为90.9%,I组有4.76%的患者和II组有2.38%的患者使用了甲氧氯普胺。在6 - 24小时,I组97.6%的患者和II组100%的患者未发生呕吐。两组的总有效率均为95.2%,两组均有2.38%的患者使用了甲氧氯普胺。总之,在接受腹腔镜手术的患者麻醉诱导后,8毫克地塞米松与1毫克格拉司琼或4毫克昂丹司琼联合使用,在止吐疗效方面无统计学显著差异,副作用最小,患者满意度高。